|Articles|November 1, 1998

Chronic Viral Hepatitis in the Era of Managed Care
Volume 4
Issue 12 Suppl

Chronic Hepatitis C: An Overview

Author(s)Jorge L. Herrera, MD

Download PDF: Chronic Hepatitis C: An Overview

Articles in this issue

over 27 years ago

Article

Participating Faculty

over 27 years ago

Article

An Overview of Viral Hepatitis

over 27 years ago

Article

Viral Hepatitis: Impact, Treatment, and Costs

over 27 years ago

Article

New Epidemiologic Data on Hepatitis B and C

over 27 years ago

Article

Appropriate Screening and Early Diagnosis of Hepatitis B and C

over 27 years ago

Article

Clinical Utility of HCV RNA Monitoring for Patients with Chronic Hepatitis C

over 27 years ago

Article

State-of-the-Art Interferon Therapy for Chronic Viral Hepatitis

over 27 years ago

Article

Cost Effectiveness of Treating Chronic Hepatitis B and C

over 27 years ago

Article

Chronic Hepatitis C: Impact, Diagnosis, and Treatment

over 27 years ago

Article

Selected Abstracts

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

ByChristopher Scannell, MD, PhD,John A. Romley, PhD,Rebecca Myerson, PhD,Dana Goldman, PhD,Dima Mazen Qato, PharmD, PhD, MPH

July 9th 2026

Chronic Hepatitis C: An Overview

Articles in this issue

Related Content

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Changes in Semaglutide Fills Following Expanded FDA and Medicare Policies

Trending on AJMC

FDA Advisory Panel Weighs Access to 7 Popular Peptides This Week

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Clesrovimab Demonstrates Safety Through a Second RSV Season in High-Risk Infants

Dermatology Practices Absorb Rising Prior Authorization Costs

Dry Eye Disease Is More Than "Dry Eyes": Experts Explain the 2 Types